With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be ...

Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...

Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular ...

Most side-effects linked to statins are not caused by the drugs, a new study suggests.After a comprehensive review of side-effects linked to the cholesterol-busting drugs, academics from the ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Add Yahoo as a preferred source to see more of our stories on Google. A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast ...

A new study reveals GLP-1 drugs, like semaglutide, offer health benefits beyond weight loss, including improved osteoarthritis, heart outcomes, and more.

A generic version of Vascepa, often prescribed with statins to lower heart attack risk, was recalled because oxidation is ...

Physicians used significantly lower amounts of two heart drugs in hospital settings following major price spikes on the medications, according to Cleveland Clinic research published Thursday in The ...

A drug commonly prescribed after a heart attack doesn’t seem to offer significant benefits for people who recover without lasting damage — and could pose added risks to women. In a new research trial, ...